Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bluebird Bio
Bluebird Bio
Bluebird, winding down in Europe, withdraws another rare disease gene therapy
BioPharma Dive
Thu, 10/21/21 - 11:17 pm
Bluebird Bio
gene therapy
Europe
Skysona
cerebral adrenoleukodystrophy
bluebird bio provides update on 2seventy bio spin-off
PM Live
Tue, 10/12/21 - 11:49 pm
Bluebird Bio
2seventy bio
spinoff
oncology
Bluebird bio Takes Hit with FDA Clinical Hold on Gene Therapy
BioSpace
Mon, 08/9/21 - 11:48 pm
Bluebird Bio
FDA
clinical hold
gene therapy
eli-cel
cerebral adrenoleukodystrophy
Resilience shells out $110M for bluebird bio site, kickstarting new collaboration
Endpoints
Thu, 07/29/21 - 11:05 am
resilience
Bluebird Bio
drug manufacturing
lentiviral
North Carolina
Bluebird, with little fanfare, is first to bring a second gene therapy to market
BioPharma Dive
Wed, 07/21/21 - 08:43 pm
Europe
Bluebird Bio
Skysona
cerebral adrenoleukodystrophy
gene therapy
With LentiGlobin cleared by FDA, bluebird lifts EU marketing hold on gene therapy using the same delivery mechanism
Endpoints
Fri, 07/9/21 - 09:54 am
Bluebird Bio
LentiGlobin
sickle cell disease
Zynteglo
Europe
beta thalassemia
bluebird bio Responds to Marketing Campaign Lawsuit with Countersuit
BioSpace
Wed, 07/7/21 - 10:25 pm
pharma marketing
Bluebird Bio
Spark Therapeutics
Roche
Bluebird's Zynteglo trials set to resume, putting gene therapy back on flight path to FDA filing
Fierce Pharma
Mon, 06/7/21 - 11:09 am
Bluebird Bio
Zynteglo
gene therapy
beta-thalassemia
Bluebird’s new gene therapy among three new EMA OKs ahead of FDA
Endpoints
Fri, 05/21/21 - 10:56 am
gene therapy
Bluebird Bio
EMA
GSK
Vir
COVID-19
Skysona
monoclonal antibodies
Bylvay
Roche's Spark sues gene therapy rival bluebird for using 'spark' in its marketing campaigns
Fierce Pharma
Thu, 05/20/21 - 11:15 am
Roche
Spark Therapeutics
Bluebird Bio
gene therapy
trademark
Bluebird names oncology spinoff, establishes leadership team
Fierce Biotech
Thu, 05/6/21 - 10:58 am
Bluebird Bio
spinoffs
cancer
2seventy bio
Bluebird bio lays off staffers in Europe as Zynteglo rollout hits an early reimbursement snag
Fierce Pharma
Tue, 04/20/21 - 07:38 pm
Bluebird Bio
Zynteglo
reimbursement
layoffs
Germany
gene therapy
Bluebird, PsiOxus show oncolytic virus boosts CAR-T in solid tumors
Fierce Biotech
Wed, 04/14/21 - 09:30 am
Bluebird Bio
PsiOxus
CAR-T
solid tumors
New CAR-T therapy from Bristol, Bluebird effective but too costly, ICER finds
BioPharma Dive
Tue, 04/6/21 - 11:00 pm
Bristol Myers Squibb
Bluebird Bio
ICER
Multiple Myeloma
CAR-T
Bristol Myers, bluebird bio have their BCMA CAR-T nod, but latecomer J&J could have an advantage: analysts
Fierce Pharma
Mon, 03/29/21 - 10:55 pm
Bristol Myers Squibb
Bluebird Bio
CAR-T
JNJ
Legend Biotech
Abecma
FDA approves first CAR-T cell therapy for multiple myeloma
BioPharma Dive
Mon, 03/29/21 - 10:56 pm
Bristol-Myers Squibb
Bluebird Bio
CAR-T
Multiple Myeloma
Abecma
FDA
Bluebird bio CMO quits amid a roller coaster year and upcoming split
Fierce Biotech
Wed, 03/17/21 - 10:54 am
Bluebird Bio
Blown off course, Bluebird shares tick up on positive gene therapy readout
Fierce Biotech
Mon, 03/15/21 - 10:54 am
Bluebird Bio
cALD
gene therapy
FDA
EMA begins safety review of bluebird gene therapy following AML case in related therapy
Endpoints
Fri, 03/12/21 - 10:32 am
Bluebird Bio
Zynteglo
Europe
EMA
AML
Bluebird seeks gene therapy trial restart after cancer scare
Pharmaforum
Wed, 03/10/21 - 11:27 am
Bluebird Bio
LentiGlobin
gene therapy
sickle cell disease
AML
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »